- $99.29m
- -$120.71m
- $19.09m
Brief: LENZ Therapeutics Announces Completion of Merger with Graphite Bio
Brief: Graphite Bio Inc Special Dividend Estimated To Be $1.03 Per Share
Brief: Graphite May Be Required To Pay Lenz A Termination Fee Of $7.5 Million Upon Termination Of Merger Agreement
Brief: Lenz Therapeutics And Graphite Bio Announce Merger Agreement
Brief: Graphite Bio Inc Says Co Approved Appointment Of Kimberlee Drapkin As President And CEO, On August 18
U.S. STOCKS ON THE MOVE-Graphite Bio, Leggett & Platt, Nauticus Robotics
Graphite Bio announces CFO exit, shares fall
Brief: Graphite Bio Announces Departure Of Chief Financial Officer
U.S. RESEARCH ROUNDUP-Chart Industries, Nvidia, Seagen
Brief: Graphite Bio Reports Fourth Quarter Results
U.S. RESEARCH ROUNDUP-Block, C4 Therapeutics, Westlake
U.S. STOCKS ON THE MOVE-Vascular Biogenics, Apellis Pharma, Nikola
U.S. STOCKS ON THE MOVE-Netflix, General Motors, Graphite Bio
U.S. STOCKS ON THE MOVE-Alibaba, Intuitive Machines, Nikola
U.S. STOCKS ON THE MOVE-Ebay, Unity Software, Chip stocks
Graphite Bio rises on job cuts, exploring strategic alternatives
Brief: Graphite Bio Inc - Expects To Incur Estimated Severance And Related Costs Of About $4.9 Million, Which Will Be Recorded Primarily In Q2 Of 2023
U.S. RESEARCH ROUNDUP-Enphase Energy, VF Corp, Zions Bancorporation Na
U.S. STOCKS ON THE MOVE-Gold miners, Silver miners, BlackRock